Research Article
Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris
Table 1
Characteristics of participants by intervention groups at baseline
| Characteristics | Combination therapy | Methotrexate | Value |
| Age, y, mean ± SD | 41.29 (2.34) | 47.21 (3.80) | 0.19 | Female/male, n (%) | 9 (64.2%) | 9 (64.2%) | 1.00 | Duration of disease, M, mean ± SD | 4.43 (0.84) | 7.07 (1.34) | 0.10 | Other autoimmune disease | 1 (7.14) | 1 (7.14) | 1.00 | Positive family history | 2 (14.2) | 2 (14.2) | 1.00 | Previous treatment | | | | Topical corticosteroids, n (%) | 14 (100) | 14 (100) | 1.00 | Systemic corticosteroids, n (%) | 4 (28.5) | 3 (21.4) | 0.663 | Hydroxychloroquine, n (%) | 7 (50) | 9 (64.2) | 0.445 | Mycophenolate mofetil, n (%) | 1 (7.14) | 4 (28.5) | 0.139 | Cyclosporine, n (%) | 1 (7.14) | 7 (50) | 0.012 | Methotrexate, n (%) | 1 (7.14) | 5 (35.7) | 0.065 | Systemic retinoids, n (%) | 0 | 2 (14.2) | 0.142 | Pioglitazone, n (%) | 0 | 1 (7.14) | 0.309 |
|
|